leadf
logo-loader

Proactive events

Proactive One2One Investor Forum

27 August 2020 | London

This event is now taking place in webinar format

Hearing the inside story and understanding the team behind the performance is crucial to making informed decisions. Join us at our next Proactive event to see leading growth companies make their pitch

Leading companies pitching

angle-logo.png
ANGLE PLC

ANGLE PLC develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease.

1533041083_ReNeuron-Group-Plc.PNG
ReNeuron Group PLC

ReNeuron is a leading, clinical-stage stem cell business.  Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

1557485123_open_orphan.png
Open Orphan PLC

Open Orphan is a rapidly growing specialist CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials.. It has Europe's only 24-bedroom quarantine...

1535459863_Scancell.png
Scancell Holdings PLC

Scancell's primary focus is to develop innovative immunotherapies for cancer that stimulate the body’s own immune system. A key challenge in the fight against cancer is that many tumours successfully evade the body’s own natural defences....

Meet the real story

Join our audience of astute high net worth investors, fund managers, private client brokers and analysts

Look beyond the numbers and meet the people creating the value for shareholders

Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story

Watch the event afterwards on our YouTube channel

Proactive events

The best event for investors looking for the insights that keep you a step ahead of the crowd

See more Proactive events >

One2one investor forums are suitable for sophisticated private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists. The event is not suitable for people pursuing commercial opportunities.